This website uses cookies and, in some cases, third-party cookies, to improve user experience. By clicking the button or continuing to use the website you agree to the use of cookies. To find out more, including how to change your settings, see our Cookie Policy.

Celgene 3.90% 2028-02 USD

Update! New bond issue: Celgene (NASDAQ:CELG) issued new debt notes (US151020BB94, 151020BB9) for 1.5B USD as of February 8, 2018. Tradable at TRACE OTC as of February 9, 2018. Listed at Stuttgart Stock Exchange as of April 25, 2018.

Celgene Corporation is an American biotechnology company that researches and develops medicines for cancer and inflammatory disorders. Celgene is headquartered in Summit, New Jersey.

IssuerCelgene
Stock (Group)NASDAQ:CELG
Bond TypeCorporate
CategorySenior, Callable, SEC Registered
Maturity DateFebruary 20, 2028
Residual Duration8 years, 4 months, 3 days
CurrencyUSD (United States Dollar)
Coupon TypeFixed Rate
Coupon (Yearly)3.900%
Coupon FrequencySemiannual
Minimum Lot2,000 USD
Additional Lots1,000 USD
Issue DateFebruary 20, 2018
Issued Amount1,500,000,000 USD
Issue Price99.656%
Maturity Price100.000%
Home ExchangeTRACE
Other ExchangesFrankfurt, Berlin, Stuttgart
IsinUS151020BB94
Cusip151020BB9
Issue DocumentationIssue Prospectus
IndustryBiotechnology
SectorHealth Care
CountryUnited States
RegionAmerica developed


Bonds, Corporate, Health Care, Biotechnology, America developed, United States, USD, Fixed Rate, Income


Next Celgene 3.25% 2023-02 USD

investopoli.com